- Article
Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor
- Hwani Ryu,
- Ky-Youb Nam,
- Hyo Jeong Kim,
- Jie-Young Song,
- Sang-Gu Hwang,
- Jae Sung Kim,
- Joon Kim and
- Jiyeon Ahn
More than 80% of colorectal cancer patients have adenomatous polyposis coli (APC) mutations, which induce abnormal WNT/β-catenin activation. Tankyrase (TNKS) mediates the release of active β-catenin, which occurs regardless of the ligand that translo...